An

Contouring Pancoast tumor QA Quality assurance Target volumes Thoracic

Journal

Clinical and translational radiation oncology
ISSN: 2405-6308
Titre abrégé: Clin Transl Radiat Oncol
Pays: Ireland
ID NLM: 101713416

Informations de publication

Date de publication:
Feb 2019
Historique:
received: 06 12 2018
revised: 03 01 2019
accepted: 04 01 2019
entrez: 19 2 2019
pubmed: 19 2 2019
medline: 19 2 2019
Statut: epublish

Résumé

Target delineation variability is a significant technical impediment in multi-institutional trials which employ intensity modulated radiotherapy (IMRT), as there is a real potential for clinically meaningful variances that can impact the outcomes in clinical trials. The goal of this study is to determine the variability of target delineation among participants from different institutions as part of Southwest Oncology Group (SWOG) Radiotherapy Committee's multi-institutional CT simulation scans were acquired from four patients with Pancoast tumor. Two patients had simulation 4D-CT and FDG-FDG PET-CT while two patients had 3D-CT and FDG-FDG PET-CT. Seventeen SWOG-affiliated physicians independently delineated target volumes defined as gross primary and nodal tumor volumes (GTV_P & GTV_N), clinical target volume (CTV), and planning target volume (PTV).Six board-certified thoracic radiation oncologists were designated as the 'Experts' for this study. Their delineations were used to create a simultaneous truth and performance level estimation (STAPLE) contours using ADMIRE software (Elekta AB, Sweden 2017). Individual participants' contours were then compared with Experts' STAPLE contours. When compared to the Experts' STAPLE, GTV_P had the best agreement among all participants, while GTV_N showed the lowest agreement among all participants. There were no statistically significant differences in all studied parameters for all TVs for cases with 4D-CT versus cases with 3D-CT simulation scans. High degree of inter-observer variation was noted for all target volume except for GTV_P, unveiling potentials for protocol modification for subsequent clinically meaningful improvement in target definition. Various similarity indices exist that can be used to guide multi-institutional radiotherapy delineation QA credentialing.

Identifiants

pubmed: 30775563
doi: 10.1016/j.ctro.2019.01.001
pii: S2405-6308(18)30113-7
pmc: PMC6365802
doi:

Types de publication

Journal Article

Langues

eng

Pagination

83-92

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : U10 CA029511
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA097007
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA214825
Pays : United States
Organisme : NIBIB NIH HHS
ID : R25 EB025787
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA180927
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA180803
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA225190
Pays : United States
Organisme : NCI NIH HHS
ID : U10 CA180888
Pays : United States
Organisme : NCI NIH HHS
ID : UG1 CA233324
Pays : United States
Organisme : NIDCR NIH HHS
ID : R56 DE025248
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA218148
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA154601
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

J Thorac Cardiovasc Surg. 2001 Mar;121(3):472-83
pubmed: 11241082
IEEE Trans Med Imaging. 2004 Jul;23(7):903-21
pubmed: 15250643
Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):954-60
pubmed: 15708280
Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):435-48
pubmed: 16198064
Strahlenther Onkol. 2006 Aug;182(8):450-7
pubmed: 16896591
Cancer Imaging. 2006 Sep 07;6:116-23
pubmed: 16966067
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Cancer Imaging. 2004 Mar 26;4(2):68-73
pubmed: 18250011
J Thorac Oncol. 2008 Dec;3(12):1433-8
pubmed: 19057269
Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):824-30
pubmed: 19117696
J Thorac Oncol. 2009 May;4(5):568-77
pubmed: 19357537
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):379-85
pubmed: 19467804
Eur J Cardiothorac Surg. 2009 Oct;36(4):741-6
pubmed: 19699647
Clin Cancer Res. 2009 Sep 15;15(18):5663-70
pubmed: 19723641
J Med Phys. 2008 Oct;33(4):136-40
pubmed: 19893706
Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):481-9
pubmed: 20400244
J Thorac Oncol. 2010 Jun;5(6):837-40
pubmed: 20421820
Radiother Oncol. 2010 Dec;97(3):572-8
pubmed: 20708285
J Clin Oncol. 2010 Dec 20;28(36):5301-10
pubmed: 21079134
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e391-8
pubmed: 22284035
Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1455-62
pubmed: 22401917
Am J Clin Oncol. 2012 Dec;35(6):612-7
pubmed: 23165357
Sci Transl Med. 2013 Feb 20;5(173):173sr2
pubmed: 23427246
J Natl Cancer Inst. 2013 Mar 20;105(6):387-93
pubmed: 23468460
Radiother Oncol. 2014 Jan;110(1):172-81
pubmed: 24183870
Pract Radiat Oncol. 2013 Jan-Mar;3(1):54-66
pubmed: 24674264
Pract Radiat Oncol. 2013 Jul-Sep;3(3):186-193
pubmed: 24674363
Ann Thorac Surg. 2014 Aug;98(2):402-10
pubmed: 24980603
Radiother Oncol. 2014 Sep;112(3):418-24
pubmed: 24996454
Nucl Med Biol. 2015 Apr;42(4):349-54
pubmed: 25595135
Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):911-20
pubmed: 26104943
BMC Med Imaging. 2015 Aug 12;15:29
pubmed: 26263899
Phys Med Biol. 2015 Nov 21;60(22):R323-61
pubmed: 26509844
Rep Pract Oncol Radiother. 2016 Sep-Oct;21(5):427-34
pubmed: 27489512
J Radiat Oncol. 2016 Mar;5(1):55-61
pubmed: 27570583
Clin Oncol (R Coll Radiol). 2018 Apr;30(4):225-232
pubmed: 29397271
Clin Cancer Res. 2018 Aug 1;24(15):3500-3509
pubmed: 29661779
Acta Oncol. 2018 Oct 30;:1-9
pubmed: 30375905
Psychol Rep. 1966 Aug;19(1):3-11
pubmed: 5942109
Health Aff (Millwood). 1997 May-Jun;16(3):146-50
pubmed: 9141331
Int J Radiat Oncol Biol Phys. 1997 Nov 1;39(4):841-8
pubmed: 9369132
Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):1-9
pubmed: 9747813
Int J Radiat Oncol Biol Phys. 1999 Jan 1;43(1):57-66
pubmed: 9989514

Auteurs

Hesham Elhalawani (H)

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, TX 77030, USA.

Baher Elgohari (B)

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, TX 77030, USA.

Timothy A Lin (TA)

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, TX 77030, USA.
Baylor College of Medicine, TX 77030, USA.

Abdallah S R Mohamed (ASR)

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, TX 77030, USA.
Department of Clinical Oncology and Nuclear Medicine, Alexandria University, Alexandria, Egypt.

Thomas J Fitzgerald (TJ)

Imaging and Radiation Oncology Core QA Center Rhode Island, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Fran Laurie (F)

Imaging and Radiation Oncology Core QA Center Rhode Island, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Kenneth Ulin (K)

Imaging and Radiation Oncology Core QA Center Rhode Island, University of Massachusetts Medical School, Worcester, Massachusetts, USA.

Jayashree Kalpathy-Cramer (J)

Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Massachusetts, USA.

Thomas Guerrero (T)

Department of Radiation Oncology, Beaumont Health System, Royal Oak, MI, USA.

Emma B Holliday (EB)

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, TX 77030, USA.

Gregory Russo (G)

Department of Radiation Oncology, Boston Medical Center, Massachusetts, USA.

Abhilasha Patel (A)

Department of Radiation Oncology, University of Texas Health Sciences Center at San Antonio, TX, USA.

William Jones (W)

Department of Radiation Oncology, University of Texas Health Sciences Center at San Antonio, TX, USA.

Gary V Walker (GV)

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, TX 77030, USA.
Department of Radiation Oncology, Banner MD Anderson Cancer Center, Gilbert, Arizona, USA.

Musaddiq Awan (M)

Department of Radiation Oncology, Case Western Reserve University, OH, USA.

Mehee Choi (M)

Department of Radiation Oncology, Northwestern University, IL, USA.

Roi Dagan (R)

University of Florida Health Proton Therapy Institute, FL, USA.

Omar Mahmoud (O)

Department of Radiation Oncology, University of Miami, FL, USA.

Anna Shapiro (A)

Department of Radiation Oncology, Upstate Cancer Center, SUNY Upstate Medical University, NY, USA.

Feng-Ming Spring Kong (FS)

Department of Radiation Oncology, University Hospitals Cleveland Medical Center, OH, USA.

Daniel Gomez (D)

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, TX 77030, USA.

Jing Zeng (J)

Department of Radiation Oncology, University of Washington Medical Center, WA, USA.

Roy Decker (R)

Department of Therapeutic Radiology, Yale University School of Medicine, Connecticut, USA.

Femke O B Spoelstra (FOB)

Department of Radiation Oncology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.

Laurie E Gaspar (LE)

Department of Radiation Oncology, Vanderbilt University, TN, USA.

Lisa A Kachnic (LA)

Department of Radiation Oncology, Vanderbilt University Medical Center, Tennessee, USA.

Charles R Thomas (CR)

Department of Radiation Medicine, Oregon Health & Science University, Oregon, USA.

Paul Okunieff (P)

SWOG, Department of Radiation Oncology, University of Florida College of Medicine, Florida, USA.

Clifton D Fuller (CD)

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, TX 77030, USA.

Classifications MeSH